The Adelphi Values Patient-Centered Outcomes team are proud to share the news that the Novartis-sponsored MSProDiscuss™ tool has now gone live on-line (https://msprodiscuss.com) and is available for MS clinicians to use. This Clinician-Report discussion tool is available to help MS patients and physicians evaluate and… Read More
The Adelphi Values Patient-Centered Outcomes team are proud to share the news that the FDA have qualified the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD) as measures of the core symptoms of asthma in adults and adolescents. The FDA have highlighted that “these instruments have… Read More
We are delighted that one of our posters at ISPOR EU has been peer reviewed and nominated as an award finalist. The poster titled ‘Europe-wide spread of carbapenem-resistant bacteria: Epidemiology and disease burden’ provides an overview of antibiotic resistance, a critical global health issue which is becoming increasingly prevalent across Europe… Read More
Each Christmas, instead of sending cards in the post, we at Adelphi Group provide our colleagues, partners and associates with the opportunity to nominate a worthy cause for us to donate to on their behalf.
In 2017, we supported Unicef to help make a difference for children all over the world. Read More
On Friday 28th July 2017 over 50 staff from the Adelphi Group took part in a 7 Peak Challenge – a marathon 26 mile walk through the Derbyshire and Cheshire hills located close to our UK head office. Despite the torrential rain and strong winds, everyone was proud to take part in the 9-hour hike to help raise money for two wonderful causes, The Alzheimer’s Society and East Cheshire Hospice. Read More
Adelphi Values will be presenting and exhibiting at the 22nd Annual International Meeting of ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, which takes place from 20th‑24th May 2017 in Boston, MA, USA. Read More